FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a chemical compound, namely N-[3-oxo-lupano-28-yl]-morpholine of formula (1): possessing antitumour and antimetastatic activity and representing a corrector of hepatotoxic damages caused by a tumour process and cytostatic polychemotherapy, and may be applicable in medicine as a pharmaceutic agent for reducing manifestation of morphological liver damages accompanying oncological diseases, including as a part of the integrated antitumour therapy.
EFFECT: preparation of the chemical compound possessing antitumour and antimetastatic activity.
1 cl, 10 ex, 6 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
AGENT FOR CORRECTION OF CYTOSTATIC POLYCHEMOTHERAPY WITH ANTI-INFLAMMATORY ACTIVITY | 2010 |
|
RU2425680C1 |
CORRECTOR OF CYTOSTATIC POLYCHEMOTHERAPY | 2007 |
|
RU2353623C1 |
ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
METHOD FOR CREATING BIOLOGICAL MODEL OF MODERATE GROWTH INHIBITION OF TUMOUR AND METASTASES IN LEWIS LUNG CARCINOMA WITH PROLONGED CYCLOPHOSPHANINE-INDUCED LEUKOPENIA IN MICE | 2012 |
|
RU2488173C1 |
AGENTS IMPROVING ANTICANCER AND ANTIMETASTATIC ACTIVITY OF CYTOSTATICS | 2011 |
|
RU2471496C1 |
DERIVATIVES OF CARBOXYLIC ACIDS, INHIBITORS OF METASTASIS AND AGENTS ENHANCING CHEMOTHERAPEUTIC ACTIVITY OF ANTITUMOR PREPARATIONS, METHOD FOR ENHANCING EFFECTIVENESS OF CYTOSTATICS, METHOD FOR INHIBITION OF METASTASIZING PROCESS | 2005 |
|
RU2295517C1 |
Authors
Dates
2012-09-20—Published
2011-07-19—Filed